Eclipsebio

Biotechnology ResearchUnited States11-50 Employees

Eclipsebio develops first-in-class technologies, analyses, and platforms for the development of tomorrow’s RNA-based and RNA-targeting therapies. With our extensive experience in supporting early-stage basic research to evaluating preclinical vaccines and gene therapies, we provide unparalleled support for obtaining deep insights into RNA and therapeutic biology. We offer our solutions as end-to-end partnerships, including custom assay development, for biopharma and biotech companies and as a la carte services.

Our areas of support include:
- The optimization and characterization of RNA-based vaccines and therapeutics through our eMERGE platform
- Multiomic characterization of small molecule and small oligonucleotide targets
- Robust validation of on-target, and the identification of off-target, effects from small molecule and small oligonucleotide drugs
- Deep profiling of RNA for groundbreaking discoveries in academic research

Contact us today to discover how we can provide you with the insights needed for RNA success.

Sign up for free to view info

Email Format Employee directory